Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK A consortium of consumer groups yesterday filed suit against AstraZeneca, alleging misleading and deceptive advertising and promotional campaigns for its next generation stomach medication, Nexium.
The suit was filed in U.S. Superior Court in Los Angeles “on behalf of consumers nationwide who purchased Nexium” by the AFL-CIO, the Congress of California Seniors and the California Alliance of Retired Americans.
The suit alleges that the drug company sought to preserve market share and profits as the patent on Prilosec was set to expire by scheming to convince consumers that its new drug, Nexium, was significantly better than Prilosec.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in